Logo image of BTX

BLACKROCK TECH & PRIV EQTY (BTX) Stock Overview

NYSE:BTX - US09260Q1085

7.02 USD
+0.04 (+0.57%)
Last: 9/5/2025, 8:04:01 PM
7 USD
-0.02 (-0.28%)
After Hours: 9/5/2025, 8:04:01 PM
Fundamental Rating

2

Overall BTX gets a fundamental rating of 2 out of 10. We evaluated BTX against 0 industry peers in the Unkown industry. BTX has a bad profitability rating. Also its financial health evaluation is rather negative. BTX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BTX had positive earnings in the past year.
BTX had a positive operating cash flow in the past year.
In multiple years BTX reported negative net income over the last 5 years.
In multiple years BTX reported negative operating cash flow during the last 5 years.
BTX Yearly Net Income VS EBIT VS OCF VS FCFBTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B -4B

1.2 Ratios

Industry RankSector Rank
ROA 1.99%
ROE 2.02%
ROIC N/A
ROA(3y)-22.76%
ROA(5y)-40.42%
ROE(3y)-23.08%
ROE(5y)-120.83%
ROIC(3y)N/A
ROIC(5y)N/A
BTX Yearly ROA, ROE, ROICBTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400 -500

1.3 Margins

BTX does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 655.74%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BTX Yearly Profit, Operating, Gross MarginsBTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for BTX has been reduced compared to 1 year ago.
Compared to 5 years ago, BTX has more shares outstanding
BTX has a better debt/assets ratio than last year.
BTX Yearly Shares OutstandingBTX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
BTX Yearly Total Debt VS Total AssetsBTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 35.63 indicates that BTX is not in any danger for bankruptcy at the moment.
BTX has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
A Debt/Equity ratio of 0.01 indicates that BTX is not too dependend on debt financing.
Although BTX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Altman-Z 35.63
ROIC/WACCN/A
WACCN/A
BTX Yearly LT Debt VS Equity VS FCFBTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

2.3 Liquidity

BTX has a Current Ratio of 0.03. This is a bad value and indicates that BTX is not financially healthy enough and could expect problems in meeting its short term obligations.
BTX has a Quick Ratio of 0.03. This is a bad value and indicates that BTX is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
BTX Yearly Current Assets VS Current LiabilitesBTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for BTX have decreased strongly by -81.91% in the last year.
The Revenue has grown by 23.65% in the past year. This is a very strong growth!
The Revenue for BTX have been decreasing by -22.63% on average. This is quite bad
EPS 1Y (TTM)-81.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1633.33%
Revenue 1Y (TTM)23.65%
Revenue growth 3Y-14.65%
Revenue growth 5Y-22.63%
Sales Q2Q%-20%

3.2 Future

BTX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.02% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y22.47%
EPS Next 2Y18.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BTX Yearly Revenue VS EstimatesBTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BTX Yearly EPS VS EstimatesBTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -20 -40 -60

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BTX is valuated quite expensively with a Price/Earnings ratio of 41.29.
When comparing the Price/Earnings ratio of BTX to the average of the S&P500 Index (27.06), we can say BTX is valued expensively.
BTX is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 41.29
Fwd PE N/A
BTX Price Earnings VS Forward Price EarningsBTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF 5.4
EV/EBITDA N/A
BTX Per share dataBTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BTX does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as BTX's earnings are expected to grow with 18.02% in the coming years.
PEG (NY)1.84
PEG (5Y)N/A
EPS Next 2Y18.02%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BTX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLACKROCK TECH & PRIV EQTY

NYSE:BTX (9/5/2025, 8:04:01 PM)

After market: 7 -0.02 (-0.28%)

7.02

+0.04 (+0.57%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-11 2022-08-11/amc
Earnings (Next)11-17 2022-11-17/bmo
Inst Owners20.88%
Inst Owner Change0%
Ins Owners0.02%
Ins Owner Change0%
Market Cap0
Analysts80
Price TargetN/A
Short Float %0.46%
Short Ratio1.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP513.89%
Div Incr Years1
Div Non Decr Years1
Ex-Date08-15 2025-08-15 (0.07884)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 41.29
Fwd PE N/A
P/S 272.36
P/FCF 5.4
P/OCF 5.4
P/B 0.84
P/tB 0.84
EV/EBITDA N/A
EPS(TTM)0.17
EY2.42%
EPS(NY)-7.99
Fwd EYN/A
FCF(TTM)1.3
FCFY18.53%
OCF(TTM)1.3
OCFY18.53%
SpS0.03
BVpS8.38
TBVpS8.38
PEG (NY)1.84
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.99%
ROE 2.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 655.74%
GM N/A
FCFM 5045.54%
ROA(3y)-22.76%
ROA(5y)-40.42%
ROE(3y)-23.08%
ROE(5y)-120.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 769.44%
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z 35.63
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1633.33%
EPS Next Y22.47%
EPS Next 2Y18.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.65%
Revenue growth 3Y-14.65%
Revenue growth 5Y-22.63%
Sales Q2Q%-20%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y27.65%
FCF growth 3YN/A
FCF growth 5Y178.61%
OCF growth 1Y27.65%
OCF growth 3YN/A
OCF growth 5Y151.66%